vs

Side-by-side financial comparison of FLANIGANS ENTERPRISES INC (BDL) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Health Catalyst, Inc. is the larger business by last-quarter revenue ($74.7M vs $52.6M, roughly 1.4× FLANIGANS ENTERPRISES INC). FLANIGANS ENTERPRISES INC runs the higher net margin — 1.5% vs -121.9%, a 123.4% gap on every dollar of revenue. On growth, FLANIGANS ENTERPRISES INC posted the faster year-over-year revenue change (4.6% vs -6.2%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $4.5M). Over the past eight quarters, FLANIGANS ENTERPRISES INC's revenue compounded faster (4.6% CAGR vs -0.0%).

Flanigans Enterprises Inc. is a U.S.-based hospitality company focused on the Florida market. It operates a chain of casual dining restaurants under the Flanigan's Seafood Bar and Grill brand, plus retail package liquor stores. Its key customer segments include local residents and regional tourists, offering affordably priced seafood, American comfort food and assorted beverages.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

BDL vs HCAT — Head-to-Head

Bigger by revenue
HCAT
HCAT
1.4× larger
HCAT
$74.7M
$52.6M
BDL
Growing faster (revenue YoY)
BDL
BDL
+10.8% gap
BDL
4.6%
-6.2%
HCAT
Higher net margin
BDL
BDL
123.4% more per $
BDL
1.5%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$5.2M more FCF
HCAT
$9.6M
$4.5M
BDL
Faster 2-yr revenue CAGR
BDL
BDL
Annualised
BDL
4.6%
-0.0%
HCAT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BDL
BDL
HCAT
HCAT
Revenue
$52.6M
$74.7M
Net Profit
$805.0K
$-91.0M
Gross Margin
Operating Margin
3.2%
-115.3%
Net Margin
1.5%
-121.9%
Revenue YoY
4.6%
-6.2%
Net Profit YoY
1363.6%
-340.3%
EPS (diluted)
$0.43
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDL
BDL
HCAT
HCAT
Q4 25
$52.6M
$74.7M
Q3 25
$50.0M
$76.3M
Q2 25
$51.9M
$80.7M
Q1 25
$53.4M
$79.4M
Q4 24
$50.0M
$79.6M
Q3 24
$45.4M
$76.4M
Q2 24
$48.8M
$75.9M
Q1 24
$48.1M
$74.7M
Net Profit
BDL
BDL
HCAT
HCAT
Q4 25
$805.0K
$-91.0M
Q3 25
$896.0K
$-22.2M
Q2 25
$1.4M
$-41.0M
Q1 25
$2.7M
$-23.7M
Q4 24
$55.0K
$-20.7M
Q3 24
$184.0K
$-14.7M
Q2 24
$1.1M
$-13.5M
Q1 24
$1.9M
$-20.6M
Gross Margin
BDL
BDL
HCAT
HCAT
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
BDL
BDL
HCAT
HCAT
Q4 25
3.2%
-115.3%
Q3 25
3.3%
-22.9%
Q2 25
5.5%
-46.0%
Q1 25
6.6%
-25.4%
Q4 24
1.5%
-22.0%
Q3 24
0.7%
-17.9%
Q2 24
4.4%
-20.8%
Q1 24
5.6%
-30.5%
Net Margin
BDL
BDL
HCAT
HCAT
Q4 25
1.5%
-121.9%
Q3 25
1.8%
-29.1%
Q2 25
2.7%
-50.8%
Q1 25
5.0%
-29.9%
Q4 24
0.1%
-26.0%
Q3 24
0.4%
-19.3%
Q2 24
2.3%
-17.8%
Q1 24
4.0%
-27.6%
EPS (diluted)
BDL
BDL
HCAT
HCAT
Q4 25
$0.43
$-1.29
Q3 25
$0.48
$-0.32
Q2 25
$0.75
$-0.59
Q1 25
$1.45
$-0.35
Q4 24
$0.03
$-0.33
Q3 24
$0.11
$-0.24
Q2 24
$0.60
$-0.23
Q1 24
$1.04
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDL
BDL
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$95.7M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$66.0M
$245.8M
Total Assets
$142.1M
$502.6M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDL
BDL
HCAT
HCAT
Q4 25
$95.7M
Q3 25
$91.5M
Q2 25
$732.0K
$97.3M
Q1 25
$244.0K
$342.0M
Q4 24
$392.0M
Q3 24
$387.3M
Q2 24
$308.3M
Q1 24
$327.8M
Total Debt
BDL
BDL
HCAT
HCAT
Q4 25
$153.3M
Q3 25
$20.9M
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$22.2M
$345.0M
Q2 24
Q1 24
Stockholders' Equity
BDL
BDL
HCAT
HCAT
Q4 25
$66.0M
$245.8M
Q3 25
$65.2M
$331.9M
Q2 25
$64.3M
$347.5M
Q1 25
$64.0M
$376.8M
Q4 24
$61.6M
$365.2M
Q3 24
$61.2M
$355.0M
Q2 24
$61.3M
$357.0M
Q1 24
$61.1M
$357.2M
Total Assets
BDL
BDL
HCAT
HCAT
Q4 25
$142.1M
$502.6M
Q3 25
$140.6M
$587.1M
Q2 25
$140.7M
$616.2M
Q1 25
$143.3M
$891.5M
Q4 24
$146.9M
$858.9M
Q3 24
$142.1M
$813.0M
Q2 24
$143.1M
$691.7M
Q1 24
$144.4M
$695.1M
Debt / Equity
BDL
BDL
HCAT
HCAT
Q4 25
0.62×
Q3 25
0.32×
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.36×
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDL
BDL
HCAT
HCAT
Operating Cash FlowLast quarter
$4.9M
$9.9M
Free Cash FlowOCF − Capex
$4.5M
$9.6M
FCF MarginFCF / Revenue
8.5%
12.9%
Capex IntensityCapex / Revenue
0.9%
0.4%
Cash ConversionOCF / Net Profit
6.14×
TTM Free Cash FlowTrailing 4 quarters
$2.2M
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDL
BDL
HCAT
HCAT
Q4 25
$4.9M
$9.9M
Q3 25
$3.4M
$-464.0K
Q2 25
$1.4M
$-9.0M
Q1 25
$-2.0M
$280.0K
Q4 24
$7.7M
$-3.5M
Q3 24
$6.2M
Q2 24
$3.1M
$1.6M
Q1 24
$10.3M
Free Cash Flow
BDL
BDL
HCAT
HCAT
Q4 25
$4.5M
$9.6M
Q3 25
$2.4M
$-719.0K
Q2 25
$-1.8M
$-9.2M
Q1 25
$-3.0M
$-390.0K
Q4 24
$7.0M
$-3.9M
Q3 24
$5.5M
Q2 24
$2.2M
$1.3M
Q1 24
$10.1M
FCF Margin
BDL
BDL
HCAT
HCAT
Q4 25
8.5%
12.9%
Q3 25
4.9%
-0.9%
Q2 25
-3.4%
-11.4%
Q1 25
-5.5%
-0.5%
Q4 24
13.9%
-4.9%
Q3 24
7.2%
Q2 24
4.5%
1.7%
Q1 24
13.5%
Capex Intensity
BDL
BDL
HCAT
HCAT
Q4 25
0.9%
0.4%
Q3 25
1.9%
0.3%
Q2 25
6.1%
0.3%
Q1 25
1.8%
0.8%
Q4 24
1.5%
0.5%
Q3 24
0.9%
Q2 24
1.8%
0.4%
Q1 24
0.3%
Cash Conversion
BDL
BDL
HCAT
HCAT
Q4 25
6.14×
Q3 25
3.75×
Q2 25
1.02×
Q1 25
-0.73×
Q4 24
140.02×
Q3 24
Q2 24
2.75×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDL
BDL

Restaurant Food Sales$30.9M59%
Package Store Sales$13.3M25%
Restaurant Bar Sales$7.9M15%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons